By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

International AIDS Vaccine Initiative 

110 William Street

New York  New York  10038-3901  U.S.A.
Phone: 212-847-1111 Fax: 212-847-1112


SEARCH JOBS








Company News
Selexis SA And International AIDS Vaccine Initiative Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing 9/22/2016 11:11:55 AM
International AIDS Vaccine Initiative Release: New Vaccination Strategies Successfully Coach Immune System To Make Powerful HIV-Neutralizing Antibodies 9/9/2016 10:10:23 AM
International AIDS Vaccine Initiative Awarded NIH Contract to Expedite AIDS Vaccine Development 8/9/2016 7:36:52 AM
International AIDS Vaccine Initiative Release: Insights Into The Development Of Antibodies That Target A Large Portion Of HIV Strains Could Advance Vaccine Design 5/17/2016 11:47:40 AM
International AIDS Vaccine Initiative Names Dr. Mark Feinberg New President And CEO 8/12/2015 2:33:10 PM
New Microsphere-Based Methods For Detecting HIV Antibodies, International AIDS Vaccine Initiative Study 5/24/2013 8:25:35 AM
International AIDS Vaccine Initiative Welcomes New Members to Board of Directors 7/31/2012 9:52:37 AM
International AIDS Vaccine Initiative Welcomes Louis Schwartz as Chief Financial Officer 5/30/2012 9:53:12 AM
International AIDS Vaccine Initiative, GlycoMimetics, Inc., and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate 5/9/2012 10:31:56 AM
International AIDS Vaccine Initiative and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2/21/2012 12:10:01 PM
123456
//-->